Next Article in Journal
Effect of Crosslinking Agent Concentration on the Properties of Unmedicated Hydrogels
Next Article in Special Issue
Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells
Previous Article in Journal
Facilitation of Drug Transport across the Blood–Brain Barrier with Ultrasound and Microbubbles
Previous Article in Special Issue
Development of Biodegradable Polycation-Based Inhalable Dry Gene Powders by Spray Freeze Drying
Open AccessArticle

Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis

Department of Pharmaceutical Science, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Academic Editor: Keiji Itaka
Pharmaceutics 2015, 7(3), 294-304; https://doi.org/10.3390/pharmaceutics7030294
Received: 8 June 2015 / Revised: 19 August 2015 / Accepted: 20 August 2015 / Published: 7 September 2015
(This article belongs to the Special Issue New Paradigm of Gene Therapy)
The small interfering RNA (siRNA) is suggested to offer a novel means of treating atopic dermatitis (AD) because it allows the specific silencing of genes related to AD pathogenesis. In our previous study, we found that siRNA targeted against RelA, an important nuclear factor-kappa B (NF-κB) subdomain, with functional peptides, showed therapeutic effects in a mouse model of AD. In the present study, to develop a topical skin application against AD, we prepared a hydrogel containing anti-RelA siRNA and functional peptides and determined the intradermal permeation and the anti-AD effects in an AD mouse model. We selected the silk protein, sericin (SC), which is a versatile biocompatible biomaterial to prepare hydrogel as an aqueous gel base. We found that the siRNA was more widely delivered to the site of application in AD-induced ear skin of mice after topical application via the hydrogel containing functional peptides than via the preparation without functional peptides. In addition, the ear thickness and clinical skin severity of the AD-induced mice treated with hydrogel containing anti-RelA siRNA with functional peptides improved more than that of mice treated with the preparation formulated with negative siRNA. View Full-Text
Keywords: atopic dermatitis; skin topical application; siRNAs; NF-κB; sericin; hydrogel atopic dermatitis; skin topical application; siRNAs; NF-κB; sericin; hydrogel
Show Figures

Graphical abstract

MDPI and ACS Style

Kanazawa, T.; Shizawa, Y.; Takeuchi, M.; Tamano, K.; Ibaraki, H.; Seta, Y.; Takashima, Y.; Okada, H. Topical Anti-Nuclear Factor-Kappa B Small Interfering RNA with Functional Peptides Containing Sericin-Based Hydrogel for Atopic Dermatitis. Pharmaceutics 2015, 7, 294-304.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop